Flownamics

Flownamics is a provider of automated bioprocess sampling and automation technologies, leveraging its patented Segmented Sampling Technology. Its core products, like the Seg-Flow systems, enable sterile, cell-free sample withdrawal from bioreactors for integration with online analyzers (e.g., HPLC, Raman spectrometers, cell counters), reducing manual intervention and contamination risk. The company targets the growing bioprocess optimization market, supporting cell & gene therapy, upstream/downstream processing, and aims to be the preferred supplier through customized solutions and service. It operates as a private, revenue-generating hardware/software platform company.

Patented Segmented Sampling Technology for automated, sterile, cell-free sampling from bioreactors, integrated with a platform of hardware (Seg-Flow S3, PS, Acquire Peltier+) and software for bioprocess automation and analytical instrument connectivity.

Flownamics competes in the bioprocess sampling and automation niche against divisions of large conglomerates like Thermo Fisher and Cytiva (Danaher), which offer broader bioreactor suites. It also faces competition from other specialized automation firms and must differentiate through its focused technology, proven integrations, and application expertise in sensitive processes like cell therapy.